Professor , University of Nevada Reno School of Medicine , United States .
Dr. Seungil Ro is a renowned professor at the University of Nevada, Reno, specializing in Physiology and Cell Biology. With an extensive career in molecular research, he has significantly contributed to the fields of smooth muscle physiology, microRNA, and gastrointestinal motility. His pioneering work has earned him several patents and leadership roles in academic programs.
Profile
Scopus
Education
Dr. Ro received his B.S. (1992) and M.S. (1994) in Molecular Biology from Wonkwang University, Korea. He further pursued another M.S. in Biological Sciences (1999) at California State University, Sacramento, followed by a Ph.D. in Cell & Molecular Biology (2002) from the University of Nevada, Reno, where he was mentored by Dr. Burton Horowitz.
Professional Experience
Dr. Ro has been a faculty member at the University of Nevada School of Medicine since 2004. He progressed from a Research Assistant Professor to his current position as a tenured Professor of Physiology & Cell Biology. From 2019 to 2023, he served as Director of the Cellular Molecular Pharmacology Physiology Graduate Program, where he guided both research and curriculum development.
Research Interests
Dr. Ro’s research focuses on molecular mechanisms in gastrointestinal smooth muscle cells, including microRNA regulation, ion channel function, and the role of interstitial cells of Cajal. His groundbreaking work in microRNA’s role in gastrointestinal diseases and obesity has resulted in various innovative treatments.
Awards
Dr. Ro has received numerous accolades, including the 2019 patent for his work on miR-10 mimics and targets in treating diabetes and gastrointestinal motility disorders. His academic contributions continue to be recognized globally, bolstered by several prestigious patents.
Publications
Dr. Ro has published extensively in high-impact journals, including:
Conclusion
Dr. Seungil Ro is a highly accomplished researcher whose work in molecular biology, cell biology, and biotechnology is transformative, particularly in the areas of disease treatment through miRNA and siRNA technologies. His innovative contributions, leadership, and extensive publication record make him a strong candidate for the Best Researcher Award. Improving in grant acquisition and public outreach could further enhance his standing in the scientific community, but his current body of work speaks to a profound impact in both academic and applied research.